from PR Newswire
Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
May 20, 2013
from PR Newswire
It was a muted start for U.S. equities when the stock market today (Monday) opened. But by mid-day, the bulls were back and benchmarks marched higher. Just before noon, the Dow Jones Industrial Average... Read More
from Money Morning
Pharma M&A – Actavis to Acquire Warner Chilcott
May 20, 2013
May 20 (Reuters) - Generic drugmaker Actavis Inc, itself the subject of takeover speculation, said on Monday it would buy specialty pharmaceutical company Warner Chilcott Plc for $5 billion in stock to... Read More
category
companyNews
Early Movers: YHOO, CPB, BA, GE & More
May 20, 2013
from CNBC.com News
Final Trade: Your First Move for Monday, May 20
May 17, 2013
from CNBC.com News
NEW YORK, May 17 (Reuters) - U.S. generic drugmaker Actavis , the subject of intense takeover speculation, may have found its best defense: a potential purchase of Warner Chilcott Plc, a specialty... Read More
category
companyNews
Valeant Pharmaceuticals’ (VRX) first quarter 2013 earnings of $1.27 (excluding special items but... Visit StockBlogHub to view complete post. Read More
from Stock Blog Hub
Novartis says has no intention of buying Actavis
May 16, 2013
ZURICH, May 16 (Reuters) - Novartis has no plans to bid for U.S.-based generic drugmaker Actavis, which is the subject of intense takeover speculation, a spokesman for the Swiss drugmaker said on... Read More
category
companyNews
Early Movers: WMT, KSS, CSCO & More
May 16, 2013
from CNBC.com News
Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of Directors
May 15, 2013
from PR Newswire
NEW YORK, May 14 (Reuters) - Actavis Inc received and rejected a takeover offer from Mylan Inc last week that valued the generic drugmaker at more than $15 billion, a person familiar with the situation... Read More
category
companyNews
Mandel's Lone Pine Capital Enters H&R Block (HRB), CME (CME), Valeant (VRX); Liquidates Facebook (FB)
May 14, 2013
from PR Newswire
Benzinga's M&A Chatter for Friday May 10, 2013
May 11, 2013
Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance Proposal
May 10, 2013
from PR Newswire
Actavis Spikes Higher on Warner Chilcott Bid Chatter
May 10, 2013
Why I stopped using stop loss orders
May 09, 2013
A big problem with stop losses is that you give up control of your sell order. During volatile markets, that can cost you money. But there is an alternative, writes Michael Sincere. Read More
from MarketWatch
from ACCESSWIRE
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here